← FDA Drug Approvals (Drugs@FDA)
ERYTHROMYCIN LACTOBIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2024-11-19
Drug application
- FDA Application #
ANDA216761- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERYTHROMYCIN LACTOBIONATE
- Generic name
- ERYTHROMYCIN LACTOBIONATE
- Active ingredients
- ERYTHROMYCIN LACTOBIONATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- Gland Pharma Limited
- First approval
- 2024-11-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown